Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Neoral vs Bitherapy in Renal Transplantation
NCT00461825Phase 3Completed
- Sponsor
- CHU de Poitiers
- Start
- Jul 1998
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in kidney transplantation comparing Group A: CsA + Azathioprine, Group B: CsA + CellCept and Group C: CsAm (3 arms). Primary endpoints: Incidence and delay of occurrence of graft dysfunction episode, Causes of graft dysfunction episodes diagnosed by graft biopsy and 1 more. Started Jul 1998; status: completed.
02
Drugs
cyclosporinemycophenolate mofetilazathioprine
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00461825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461825.